121 related articles for article (PubMed ID: 18615936)
1. Increasing prevalence of cocaine as the primary detoxification diagnosis among admissions presenting with current intravenous drug use: a review of detoxification records from northern British Columbia, 1999-2005.
Callaghan RC; Strike C; Kerr T; Fischer B; Buxton J; Stevens E; Taylor L; Victor JC
Can J Public Health; 2008; 99(3):178-81. PubMed ID: 18615936
[TBL] [Abstract][Full Text] [Related]
2. Mobility patterns of Aboriginal injection drug users between on- and off-reserve settings in northern British Columbia, Canada.
Callaghan RC; Tavares J; Taylor L
Int J Circumpolar Health; 2007 Jun; 66(3):241-7. PubMed ID: 17655064
[TBL] [Abstract][Full Text] [Related]
3. Hospital utilization and costs in a cohort of injection drug users.
Palepu A; Tyndall MW; Leon H; Muller J; O'Shaughnessy MV; Schechter MT; Anis AH
CMAJ; 2001 Aug; 165(4):415-20. PubMed ID: 11531049
[TBL] [Abstract][Full Text] [Related]
4. Intravenous and non-intravenous cocaine abusers admitted to inpatient detoxification treatment: a 3-year medical-chart review of patient characteristics and predictors of treatment re-admission.
Callaghan RC; Cunningham JA
Drug Alcohol Depend; 2002 Dec; 68(3):323-8. PubMed ID: 12393226
[TBL] [Abstract][Full Text] [Related]
5. An examination of injection drug use trends in Victoria and Vancouver, BC after the closure of Victoria's only fixed-site needle and syringe programme.
Ivsins A; Chow C; Macdonald S; Stockwell T; Vallance K; Marsh DC; Michelow W; Duff C
Int J Drug Policy; 2012 Jul; 23(4):338-40. PubMed ID: 22280916
[TBL] [Abstract][Full Text] [Related]
6. A gendered analysis of Canadian Aboriginal individuals admitted to inpatient substance abuse detoxification: a three-year medical chart review.
Callaghan RC; Cull R; Vettese LC; Taylor L
Am J Addict; 2006; 15(5):380-6. PubMed ID: 16966194
[TBL] [Abstract][Full Text] [Related]
7. Injecting drugs in tight spaces: HIV, cocaine and collinearity in the Downtown Eastside, Vancouver, Canada.
Ciccarone D; Bourgois P
Int J Drug Policy; 2016 Jul; 33():36-43. PubMed ID: 27117187
[TBL] [Abstract][Full Text] [Related]
8. Harm reduction product distribution in British Columbia.
Harvard SS; Hill WD; Buxton JA
Can J Public Health; 2008; 99(6):446-50. PubMed ID: 19149383
[TBL] [Abstract][Full Text] [Related]
9. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.
Miller CL; Kerr T; Frankish JC; Spittal PM; Li K; Schechter MT; Wood E
Subst Use Misuse; 2006; 41(2):199-210. PubMed ID: 16393742
[TBL] [Abstract][Full Text] [Related]
10. Needle-exchange attendance and health care utilization promote entry into detoxification.
Strathdee SA; Celentano DD; Shah N; Lyles C; Stambolis VA; Macalino G; Nelson K; Vlahov D
J Urban Health; 1999 Dec; 76(4):448-60. PubMed ID: 10609594
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
Miller CL; Strathdee SA; Li K; Kerr T; Wood E
Am J Drug Alcohol Abuse; 2007; 33(4):527-36. PubMed ID: 17668338
[TBL] [Abstract][Full Text] [Related]
12. Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.
Lloyd-Smith E; Wood E; Li K; Montaner JS; Kerr T
Drug Alcohol Depend; 2009 Jan; 99(1-3):176-82. PubMed ID: 18805655
[TBL] [Abstract][Full Text] [Related]
13. Recent incarceration independently associated with syringe sharing by injection drug users.
Wood E; Li K; Small W; Montaner JS; Schechter MT; Kerr T
Public Health Rep; 2005; 120(2):150-6. PubMed ID: 15842116
[TBL] [Abstract][Full Text] [Related]
14. Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal.
De P; Jolly A; Cox J; Boivin JF
Can J Public Health; 2006; 97(3):207-9. PubMed ID: 16827407
[TBL] [Abstract][Full Text] [Related]
15. HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs.
Razak MH; Jittiwutikarn J; Suriyanon V; Vongchak T; Srirak N; Beyrer C; Kawichai S; Tovanabutra S; Rungruengthanakit K; Sawanpanyalert P; Celentano DD
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):259-66. PubMed ID: 12794564
[TBL] [Abstract][Full Text] [Related]
16. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities.
Mehrabadi A; Craib KJ; Patterson K; Adam W; Moniruzzaman A; Ward-Burkitt B; Schechter MT; Spittal PM;
Int J Drug Policy; 2008 Apr; 19(2):159-68. PubMed ID: 17870461
[TBL] [Abstract][Full Text] [Related]
17. Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.
Janjua NZ; Islam N; Kuo M; Yu A; Wong S; Butt ZA; Gilbert M; Buxton J; Chapinal N; Samji H; Chong M; Alvarez M; Wong J; Tyndall MW; Krajden M;
Int J Drug Policy; 2018 May; 55():31-39. PubMed ID: 29482150
[TBL] [Abstract][Full Text] [Related]
18. HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies.
Werb D; Kerr T; Small W; Li K; Montaner J; Wood E
J Public Health (Oxf); 2008 Jun; 30(2):126-32. PubMed ID: 18387974
[TBL] [Abstract][Full Text] [Related]
19. The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study.
Hayden A; Hayashi K; Dong H; Milloy MJ; Kerr T; Montaner JS; Wood E
BMC Public Health; 2014 Nov; 14():1153. PubMed ID: 25377274
[TBL] [Abstract][Full Text] [Related]
20. A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012.
Kuo M; Shamsian A; Tzemis D; Buxton JA
Harm Reduct J; 2014 Apr; 11():13. PubMed ID: 24766846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
